Nigel B. Jamieson

33.0k total citations
105 papers, 4.1k citations indexed

About

Nigel B. Jamieson is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Nigel B. Jamieson has authored 105 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Oncology, 34 papers in Cancer Research and 30 papers in Surgery. Recurrent topics in Nigel B. Jamieson's work include Pancreatic and Hepatic Oncology Research (68 papers), Cancer Genomics and Diagnostics (26 papers) and Pancreatitis Pathology and Treatment (21 papers). Nigel B. Jamieson is often cited by papers focused on Pancreatic and Hepatic Oncology Research (68 papers), Cancer Genomics and Diagnostics (26 papers) and Pancreatitis Pathology and Treatment (21 papers). Nigel B. Jamieson collaborates with scholars based in United Kingdom, Australia and Netherlands. Nigel B. Jamieson's co-authors include Colin J. McKay, Karin A. Oien, Jennifer P. Morton, Owen J. Sansom, Euan J. Dickson, Donald C. McMillan, C W Imrie, Ross Carter, T.R. Jeffry Evans and Alan K. Foulis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Nigel B. Jamieson

95 papers receiving 4.1k citations

Peers

Nigel B. Jamieson
Nigel B. Jamieson
Citations per year, relative to Nigel B. Jamieson Nigel B. Jamieson (= 1×) peers Gerald W. Prager

Countries citing papers authored by Nigel B. Jamieson

Since Specialization
Citations

This map shows the geographic impact of Nigel B. Jamieson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nigel B. Jamieson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nigel B. Jamieson more than expected).

Fields of papers citing papers by Nigel B. Jamieson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nigel B. Jamieson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nigel B. Jamieson. The network helps show where Nigel B. Jamieson may publish in the future.

Co-authorship network of co-authors of Nigel B. Jamieson

This figure shows the co-authorship network connecting the top 25 collaborators of Nigel B. Jamieson. A scholar is included among the top collaborators of Nigel B. Jamieson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nigel B. Jamieson. Nigel B. Jamieson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bigley, Christopher, Kathryn A.F. Pennel, Antonia K. Roseweir, et al.. (2025). Investigation of three alternative histopathological scoring methods at the invasive tumour front in colorectal cancer. The Journal of Pathology Clinical Research. 11(3). e70031–e70031.
2.
Bokhorst, John‐Melle, Shannon van Vliet, Kiek Verrijp, et al.. (2025). Tumor budding and poorly differentiated clusters as a biological continuum in colorectal cancer invasion and prognosis. Scientific Reports. 15(1). 16944–16944.
5.
Jamieson, Nigel B., et al.. (2024). Pancreatic cancer. Surgery (Oxford). 43(1). 26–37. 1 indexed citations
6.
Brouwer, Nelleke P.M., Shannon van Vliet, Pascal W.T.C. Jansen, et al.. (2023). Transcriptomics and proteomics reveal distinct biology for lymph node metastases and tumour deposits in colorectal cancer. The Journal of Pathology. 261(4). 401–412. 15 indexed citations
7.
Sykes, Robert, Karla B Neves, Rhéure Alves-Lopes, et al.. (2023). Vascular mechanisms of post-COVID-19 conditions: Rho-kinase is a novel target for therapy. European Heart Journal - Cardiovascular Pharmacotherapy. 9(4). 371–386. 10 indexed citations
8.
Pennel, Kathryn A.F., Andrew J. Cameron, Jean A. Quinn, et al.. (2023). Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases. Cancer Research. 83(8). 1329–1344. 19 indexed citations
9.
Pennel, Kathryn A.F., Elizabeth Mallon, Ditte K. Andersen, et al.. (2023). High expression of STAT3 within the tumour‐associated stroma predicts poor outcome in breast cancer patients. Cancer Medicine. 12(12). 13225–13240. 17 indexed citations
10.
Halle‐Smith, James, Lois A. Daamen, James Hodson, et al.. (2021). Clinical benefit of surveillance after resection of pancreatic ductal adenocarcinoma: A systematic review and meta-analysis. European Journal of Surgical Oncology. 47(9). 2248–2255. 13 indexed citations
11.
Steele, Colin W., et al.. (2016). Targeting inflammation in pancreatic cancer: Clinical translation. World Journal of Gastrointestinal Oncology. 8(4). 380–380. 16 indexed citations
12.
Jamieson, Nigel B., Sean M. Grimmond, Andrew V. Biankin, & David K. Chang. (2014). Pancreatic cancer: challenges for therapeutic development. ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam). 1 indexed citations
13.
Mackellar, Joanne & Nigel B. Jamieson. (2014). Assessing the contribution of a major cycle race to host communities in South Australia. Leisure Studies. 34(5). 547–565. 9 indexed citations
14.
Denley, S, Nigel B. Jamieson, Karin A. Oien, et al.. (2013). Activation of the IL-6R/Jak/Stat Pathway is Associated with a Poor Outcome in Resected Pancreatic Ductal Adenocarcinoma. Journal of Gastrointestinal Surgery. 17(5). 887–898. 79 indexed citations
15.
Velu, Lavanniya K. P., Donald C. McMillan, Colin J. McKay, et al.. (2013). Serum amylase on the night of surgery predicts clinically significant pancreatic fistula after pancreaticoduodenectomy. HPB. 16(7). 610–619. 66 indexed citations
16.
Jamieson, Nigel B., Jennifer P. Morton, Asif Ali, et al.. (2011). MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research. 18(2). 534–545. 175 indexed citations
17.
Jamieson, Nigel B., et al.. (2011). Tissue Biomarkers for Prognosis in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-analysis. Clinical Cancer Research. 17(10). 3316–3331. 103 indexed citations
19.
Jamieson, Nigel B., S Denley, Jennifer Logue, et al.. (2011). A Prospective Comparison of the Prognostic Value of Tumor- and Patient-Related Factors in Patients Undergoing Potentially Curative Surgery for Pancreatic Ductal Adenocarcinoma. Annals of Surgical Oncology. 18(8). 2318–2328. 101 indexed citations
20.
Morton, Jennifer P., Paul Timpson, Saadia A. Karim, et al.. (2009). Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer. Proceedings of the National Academy of Sciences. 107(1). 246–251. 465 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026